thiosulfates has been researched along with Acute Coronary Syndrome in 1 studies
Thiosulfates: Inorganic salts of thiosulfuric acid possessing the general formula R2S2O3.
thiosulfate(2-) : A divalent inorganic anion obtained by removal of both protons from thiosulfuric acid.
Acute Coronary Syndrome: An episode of MYOCARDIAL ISCHEMIA that generally lasts longer than a transient anginal episode that ultimately may lead to MYOCARDIAL INFARCTION.
Excerpt | Relevance | Reference |
---|---|---|
"This is the first report on sodium thiosulfate administration in patients with acute coronary syndromes." | 7.96 | Safety and Tolerability of Sodium Thiosulfate in Patients with an Acute Coronary Syndrome Undergoing Coronary Angiography: A Dose-Escalation Safety Pilot Study (SAFE-ACS). ( Assa, S; de Koning, MLY; Lipsic, E; Maagdenberg, CG; Pasch, A; van der Harst, P; van Goor, H; van Veldhuisen, DJ, 2020) |
"This is the first report on sodium thiosulfate administration in patients with acute coronary syndromes." | 3.96 | Safety and Tolerability of Sodium Thiosulfate in Patients with an Acute Coronary Syndrome Undergoing Coronary Angiography: A Dose-Escalation Safety Pilot Study (SAFE-ACS). ( Assa, S; de Koning, MLY; Lipsic, E; Maagdenberg, CG; Pasch, A; van der Harst, P; van Goor, H; van Veldhuisen, DJ, 2020) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
de Koning, MLY | 1 |
Assa, S | 1 |
Maagdenberg, CG | 1 |
van Veldhuisen, DJ | 1 |
Pasch, A | 1 |
van Goor, H | 1 |
Lipsic, E | 1 |
van der Harst, P | 1 |
1 other study available for thiosulfates and Acute Coronary Syndrome
Article | Year |
---|---|
Safety and Tolerability of Sodium Thiosulfate in Patients with an Acute Coronary Syndrome Undergoing Coronary Angiography: A Dose-Escalation Safety Pilot Study (SAFE-ACS).
Topics: Acute Coronary Syndrome; Adult; Coronary Angiography; Dose-Response Relationship, Drug; Female; Huma | 2020 |